E. coli metabolic engineering for gram scale production of a plant-based anti-inflammatory agent

Metabolic Engineering

Volumn 38, Issue , 2016, Pages 382-388

  Ahmadi, Mahmoud Kamal ^a   Fang, Lei ^a   Moscatello, Nicholas ^a   Pfeifer, Blaine A ^a  

^a the State University of New York   (United States)

Author keywords

Anti inflammatory; Co culture; E. coli; Plant; Salicylate; Salicylate 2 O D glucoside

Indexed keywords

ESCHERICHIA COLI; GENE EXPRESSION; METABOLISM; NITRIC OXIDE;

ANTI-INFLAMMATORIES; CO-CULTURES; E. COLI; PLANT; SALICYLATE;

METABOLIC ENGINEERING;

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SALICYLATE 2 O BETA DEXTRO GLUCOSIDE; SALICYLIC ACID; UNCLASSIFIED DRUG; ESCHERICHIA COLI PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARABIDOPSIS THALIANA; ARTICLE; BACTERIAL GENE; BACTERIAL METABOLISM; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; DELETION MUTANT; DRUG SYNTHESIS; ESCHERICHIA COLI; GENE EXPRESSION; IN VITRO STUDY; IRP9 GENE; MACROPHAGE; METABOLIC ENGINEERING; NONHUMAN; PHEA GENE; PLANT GENE; PRIORITY JOURNAL; TRANSLATION INITIATION; TRPD GENE; TYRA GENE; ARABIDOPSIS; BIOSYNTHESIS; GENETIC ENHANCEMENT; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARABIDOPSIS; BIOSYNTHETIC PATHWAYS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENETIC ENHANCEMENT; METABOLIC ENGINEERING; METABOLIC NETWORKS AND PATHWAYS; RECOMBINANT PROTEINS; SALICYLIC ACID;

EID: 84994806228     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2016.10.001     Document Type: Article

References (32)

1. Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K.A., Tomita, M., Wanner, B.L., Mori, H., Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol., 2, 2006 (2006.0008).
2. Cane, D.E., Walsh, C.T., The parallel and convergent universe of polyketide synthases and nonribosomal peptide synthetases. Chem. Biol. 6 (1999), R319-R325.
3. Datsenko, K.A., Wanner, B.L., One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97 (2000), 6640-6645.
4. Dean, J.V., Mohammed, L.A., Fitzpatrick, T., The formation, vacuolar localization, and tonoplast transport of salicylic acid glucose conjugates in tobacco cell suspension cultures. Planta 221 (2005), 287-296.
5. Demain, A.L., Antibiotics: natural products essential to human health. Med. Res. Rev. 29 (2009), 821-842.
6. Demain, A.L., Importance of microbial natural products and the need to revitalize their discovery. J. Ind. Microbiol. Biotechnol. 41 (2014), 185-201.
7. Demain, A.L., Sanchez, S., Microbial drug discovery: 80 years of progress. J. Antibiot. Tokyo 62 (2009), 5-16.
8. Espah Borujeni, A., Channarasappa, A.S., Salis, H.M., Translation rate is controlled by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at upstream standby sites. Nucleic Acids Res. 42 (2014), 2646-2659.
9. Fischbach, M.A., Walsh, C.T., Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem. Rev. 106 (2006), 3468-3496.
10. Kamal Ahmadi, M., Fawaz, S., Jones, C.H., Zhang, G., Pfeifer, B.A., Total biosynthesis and diverse applications for the nonribosomal peptide-polyketide siderophore yersiniabactin. Appl. Environ. Microbiol. 81 (2015), 5290-5298.
11. Katz, L., Manipulation of modular polyketide synthases. Chem. Rev. 97 (1997), 2557-2576.
12. Kerbarh, O., Ciulli, A., Howard, N.I., Abell, C., Salicylate biosynthesis: overexpression, purification, and characterization of Irp9, a bifunctional salicylate synthase from Yersinia enterocolitica. J. Bacteriol. 187 (2005), 5061-5066.
13. Lee, H.I., Raskin, I., Purification, cloning, and expression of a pathogen inducible UDP-glucose: salicylic acid glucosyltransferase from tobacco. J. Biol. Chem. 274 (1999), 36637-36642.
14. Lim, E.K., Doucet, C.J., Li, Y., Elias, L., Worrall, D., Spencer, S.P., Ross, J., Bowles, D.J., The activity of Arabidopsis glycosyltransferases toward salicylic acid, 4-hydroxybenzoic acid, and other benzoates. J. Biol. Chem. 277 (2002), 586-592.
15. Lin, Y., Sun, X., Yuan, Q., Yan, Y., Extending shikimate pathway for the production of muconic acid and its precursor salicylic acid in Escherichia coli. Metab. Eng. 23 (2014), 62-69.
16. Lindsey, A.S., Jeskey, H., The Kolbe-Schmitt reaction. Chem. Rev. 57 (1957), 583-620.
17. Mao, Z., Shin, H.D., Chen, R.R., Engineering the E. coli UDP-glucose synthesis pathway for oligosaccharide synthesis. Biotechnol. Prog. 22 (2006), 369-374.
18. Ongley, S.E., Bian, X., Neilan, B.A., Muller, R., Recent advances in the heterologous expression of microbial natural product biosynthetic pathways. Nat. Prod. Rep. 30 (2013), 1121-1138.
19. Pelludat, C., Brem, D., Heesemann, J., Irp9, encoded by the high-pathogenicity island of Yersinia enterocolitica, is able to convert chorismate into salicylate, the precursor of the siderophore yersiniabactin. J. Bacteriol. 185 (2003), 5648-5653.
20. Rivas-San Vicente, M., Plasencia, J., Salicylic acid beyond defence: its role in plant growth and development. J. Exp. Bot. 62 (2011), 3321-3338.
21. Salis, H.M., Mirsky, E.A., Voigt, C.A., Automated design of synthetic ribosome binding sites to control protein expression. Nat. Biotechnol. 27 (2009), 946-950.
22. Song, J.T., Induction of a salicylic acid glucosyltransferase, AtSGT1, is an early disease response in Arabidopsis thaliana. Mol. Cells 22 (2006), 233-238.
23. Vlot, A.C., Dempsey, D.A., Klessig, D.F., Salicylic acid, a multifaceted hormone to combat disease. Annu. Rev. Phytopathol. 47 (2009), 177-206.
24. Warner, T.D., Mitchell, J.A., Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?. Proc. Natl. Acad. Sci. USA, 99, 2002, 13371-13373.
25. Weissman, K.J., Leadlay, P.F., Combinatorial biosynthesis of reduced polyketides. Nat. Rev. Microbiol 3 (2005), 925-936.
26. Xin, W., Huang, C., Zhang, X., Zhang, G., Ma, X., Sun, L., Wang, C., Zhang, D., Zhang, T., Du, G., Evaluation of the new anti-inflammatory compound ethyl salicylate 2-O-beta-d-glucoside and its possible mechanism of action. Int. Immunopharmacol. 15 (2013), 303-308.
27. Yadav, V.G., Stephanopoulos, G., Metabolic engineering: the ultimate paradigm for continuous pharmaceutical manufacturing. ChemSusChem 7 (2014), 1847-1853.
28. Zhang, D., Liu, R., Sun, L., Huang, C., Wang, C., Zhang, D.M., Zhang, T.T., Du, G.H., Anti-inflammatory activity of methyl salicylate glycosides isolated from Gaultheria yunnanensis (Franch.) Rehder. Molecules 16 (2011), 3875-3884.
29. Zhang, H., Boghigian, B.A., Armando, J., Pfeifer, B.A., Methods and options for the heterologous production of complex natural products. Nat. Prod. Rep. 28 (2011), 125-151.
30. Zhang, H., Pereira, B., Li, Z., Stephanopoulos, G., Engineering Escherichia coli co-culture systems for the production of biochemical products. Proc. Natl. Acad. Sci. USA 112 (2015), 8266-8271.
31. Zhang, H., Wang, X., Modular co-culture engineering, a new approach for metabolic engineering. Metab. Eng. 37 (2016), 114-121.
32. Zhuang, K.H., Herrgard, M.J., Multi-scale exploration of the technical, economic, and environmental dimensions of bio-based chemical production. Metab. Eng. 31 (2015), 1-12.